2015 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
December 3, 2015
Moffitt Cancer Center and Aptose Biosciences to Present Data on a Novel Class of Dual-Targeting Bromodomain / Kinase Inhibitors at 57th Annual American Society of Hematology (ASH) Meeting
November 30, 2015
Aptose Biosciences to Participate in Upcoming Investor Conferences
November 20, 2015
Aptose Voluntarily Suspends Clinical Dosing of APTO-253 to Review Drug Manufacturing Processes and Procedures
November 10, 2015
Aptose Biosciences Reports Results for the Third Quarter Ended September 30, 2015
November 10, 2015
Aptose Biosciences Announces Collaborations for New Multi-Targeting Epigenetic Therapeutic Agents
November 5, 2015
Beat AML & Aptose Biosciences Present Data for APTO-253 at the 57th American Society of Hematology (ASH) Annual Meeting
November 5, 2015
Aptose Biosciences to Host Third Quarter Ended September 30, 2015 Financial Results Conference Call and Webcast
October 15, 2015
Aptose Biosciences to Present at the 2015 BIO Investor Forum
September 28, 2015
Aptose Biosciences to Present at 15th Annual Biotech in Europe Forum
August 10, 2015
Aptose Biosciences to Present at Canaccord Genuity 35th Annual Growth Conference
August 4, 2015
Aptose Biosciences Reports Results for the Second Quarter Ended June 30, 2015
July 30, 2015
Aptose Biosciences to Host Second Quarter Ended June 30, 2015 Financial Results Conference Call and Webcast
June 22, 2015
Aptose Biosciences to Present at the 10th Annual JMP Securities Life Sciences Conference
June 10, 2015
Aptose Biosciences announces results of annual and special meeting of shareholders
June 2, 2015
Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia
May 5, 2015
Aptose Biosciences Reports Results for the First Quarter Ended March 31, 2015
April 30, 2015
Aptose Biosciences To Host First Quarter Ended March 31, 2015 Financial Results Conference Call and Webcast
March 23, 2015
Aptose Biosciences Announces Appointment of Dr. Michael Andreeff to Scientific Advisory Board
March 23, 2015
Aptose Biosciences to Present at the 12th Annual BIO Asia International Conference
March 5, 2015
Aptose Biosciences to Present at the 27th Annual ROTH Conference
March 3, 2015
Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014
February 26, 2015
Aptose Biosciences To Host Quarter and Seven Month Transition Period Ended December 31, 2014 Conference Call and Webcast
February 25, 2015
Aptose Biosciences to Present at the Cowen & Company 35th Annual Healthcare Conference
February 19, 2015
Aptose Biosciences to Present at the RBC Capital Markets 2015 Global Healthcare Conference
January 20, 2015
Aptose Biosciences Appoints Dr. Bradley Thompson to the Audit Committee
January 13, 2015
Aptose Biosciences Doses First Patient in Phase 1b Clinical Study of APTO-253 in Relapsed or Refractory Hematological Malignancies
January 12, 2015
Aptose Biosciences to Present at Biotech Showcase™ 2015